Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients

PURPOSE: The efficacy of post-surgery platinum-based chemotherapy, the primary choice for the treatment of ovarian cancer (OC), is greatly reduced by the development of drug-resistance. In this study, we investigated the association of expression low-density lipoprotein receptor (LDLR) and 3-hydroxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xueyao, Wei, Xuan, Qiao, Sijing, Zhang, Xue, Li, Rui, Hu, Shunxue, Mao, Hongluan, Liu, Peishu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664653/
https://www.ncbi.nlm.nih.gov/pubmed/34908877
http://dx.doi.org/10.2147/CMAR.S337873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664653/
https://www.ncbi.nlm.nih.gov/pubmed/34908877
http://dx.doi.org/10.2147/CMAR.S337873

Ejemplares similares